E-PaperAurobindo Pharma Q3 Results
- BSE: 524804
- NSE: AUROPHARMA
- ISIN: INE406A01037
- Sector: Major Drugs
BSE
1,330.25
25.60 (1.96%)
25.60 (1.96%)Volume33.12 K
Updated: Tue 9 Jul, 2024 | 15:29:41
NSE
1,332.427.00 (2.07%)
27.00 (2.07%)Volume1.71 M
Updated: Tue 9 Jul, 2024 | 15:32:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Aurobindo Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 23 | Sep 23 | QoQ Comp | Dec 22 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 7,351.78 | 7,219.42 | 1.83% | 6,407.13 | 14.74% |
| Selling/ General/ Admin Expenses Total | 989.68 | 954.97 | 3.63% | 921.72 | 7.37% |
| Depreciation/ Amortization | 423.27 | 417.50 | 1.38% | 321.40 | 31.70% |
| Other Operating Expenses Total | 1,610.22 | 1,624.48 | -0.88% | 1,623.44 | -0.81% |
| Total Operating Expense | 6,173.74 | 6,233.69 | -0.96% | 5,774.12 | 6.92% |
| Operating Income | 1,178.04 | 985.73 | 19.51% | 633.01 | 86.10% |
| Net Income Before Taxes | 1,262.42 | 1,075.64 | 17.36% | 680.11 | 85.62% |
| Net Income | 936.29 | 757.18 | 23.65% | 491.26 | 90.59% |
| Diluted Normalized EPS | 16.04 | 12.83 | 25.02% | 8.38 | 91.41% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Emcure Pharmaceuticals IPO listing tomorrow: Here’s what GMP, subscription status indicate ahead of listing
3 min read9 Jul 2024 - Markets
02Ganesh Green Bharat IPO booked over 78x on third day of bidding so far; retail, NII portion sees huge demand. Check GMP
3 min read9 Jul 2024 - Markets
03Stocks to buy: Heritage Foods, ONGC, among top four picks by SMC Global Securities for this week; 17-25% upside pegged
5 min read9 Jul 2024